AMPLY Discovery

AMPLY Discovery is an AI-driven drug discovery platform leveraging AI, Next Generation Sequencing, and Synthetic Biology to accelerate the discovery of cures for diseases caused by genetic variations. Its platform analyzes biological molecules, identifies treatment targets, and bio-prints molecules for testing and improvement. This approach aims to create a faster, cheaper, and more scalable drug discovery process.


Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $1.75M

Date: 01-May-2025

Investors: Twin Path Ventures, Venture Science, Co-fund NI, British Business Bank, QUBIS Limited

Markets: Biotechnology, AI, Drug Discovery, Anti-infectives, Healthcare, Genomics, Cancer, Biologics, Metabolic Diseases

HQ: Belfast, Northern Ireland, United Kingdom

Founded: 2021

Website: https://amplydiscovery.com/

LinkedIn: https://www.linkedin.com/company/amply-discovery

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/amply-discovery?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/509237-56


Leave a Comment